MedTrace Logo

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

NCT00418366 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-08-19

No results posted yet for this study

Summary

A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication

Conditions

  • Renal Insufficiency
  • Hemodialysis

Interventions

DRUG

MK0431, sitagliptin phosphate / Duration of Treatment : 1 Days

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2003-03-31
Completion
2003-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00418366 on ClinicalTrials.gov